background: In animal models, in vitro culture of preimplantation embryos has been shown to be a risk factor for abnormal fetal outcome, including high and low birthweight. In the human, mean birthweight of singletons after in vitro fertilization (IVF) is considerably lower than after natural conception, but it is not known whether culture conditions play a role in this.
Introduction
It is well established that pregnancy outcome of singleton pregnancies is considerably inferior after artificial reproduction treatments such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) compared with spontaneous conception (Helmerhorst et al., 2004; Jackson et al., 2004; Sutcliffe and Ludwig, 2007; Schieve et al., 2007; Ceelen et al., 2008; Centers for Disease Control and Prevention, 2009) . When singleton pregnancies after IVF or ICSI were compared with control groups after natural conception and matched for several maternal characteristics such as age and parity, relative risks of 2.04 (CI 1.80 -2.32) for preterm births (,37 weeks), 1.70 (CI 1.50 -1.92) for low birthweight (,2500 g) and of 1.40 (CI 1.15 -1.71) for small for gestational age (,10th percentile) were reported in a review by Helmerhorst et al. (2004) . Theoretically, this increased risk of adverse pregnancy outcome after IVF or ICSI may be the result of treatment-related factors such as in vitro culture conditions or hormonal stimulation, as well as patient-related factors such as type and duration of subfertility, and other inherent characteristics of subfertile patients (Thomson et al., 2005; De Geyter et al. 2006; Ombelet et al., 2006) . In a recent study (Romundstad et al., 2008) , no significant differences were found when birthweight and other perinatal outcome measures were compared in sibling singletons born to more than 2500 women who had conceived at least one child spontaneously and another child after IVF. These results suggest that patient-related factors, rather than the IVF technology, are responsible for the less optimal perinatal outcome after IVF (Romundstad et al., 2008) . However, in several animal models it has been shown that aspects of the IVF technology such as the use of certain culture media for in vitro culture of embryos can profoundly affect perinatal outcome including abnormal birthweight (Thompson et al., 1995; Khosla et al., 2001; Lane and Gardner, 2003; Rooke et al., 2007) . In the present study, we evaluated the effect of in vitro culture on human perinatal outcome by comparing the results of perinatal outcome of pregnancies after IVF treatment in which either one of two widely used, commercially available sequential media systems were used.
Materials and Methods

Study design
At the Maastricht University Medical Centre, all treatment cycles from couples undergoing IVF (with either standard insemination or ICSI as the fertilization method) are routinely assigned to culture in one of two widely used commercially available sequential culture media. In the present prospective study, assignment was performed by strictly alternating consecutive IVF treatments between the two media types on the day before the ovum pick up by laboratory technicians who were unaware of characteristics of the patients or treatment cycles. The order in which ovum pick ups were scheduled on a certain day, and which directly determined the allocation to a study group was planned by clinical personnel who were unaware of the allocation procedure in the laboratory. The alternate use of two culture media in our IVF treatment program is part of our internal quality monitoring system in order to be able to identify suboptimal batches of a particular medium. From July 2003 to December 2006, culture was performed either in media from Vitrolife AB (Gö teborg, Sweden) or in media from Cook (Brisbane, Australia). Except for the media, exactly the same ovarian stimulation, fertilization, culture and embryo transfer procedures were applied in both groups. For the purpose of the present analysis, only results obtained during the first IVF treatment cycles in all patients who were treated in our center during the study period were selected. Only data from pregnancies resulting from fresh embryo transfers were included. Patients applying for preimplantation genetic diagnosis and patients requiring donor oocytes were excluded. During the study period, apart from exceptional cases, only patients of 40 years of age, body mass index (BMI) of ,30 kg/m 2 and not suffering from hypertension were admitted to our IVF program. All patients gave informed consent for the use of their data. The local ethics committee approved the collection of data for quality monitoring purposes as part of our IVF treatment protocol.
Procedures
Patients were down-regulated with 0.1 mg of triptorelin daily s.c. (Decapeptyl; Ferring BV, Hoofddorp, The Netherlands) according to a long protocol. To stimulate multiple follicular development, recombinant FSH (Puregon; Organon, Oss, The Netherlands) was used. Follicle growth was monitored by ultrasound, and 5000 IU of hCG (Pregnyl; Organon) was administered as soon as at least three follicles were 18 mm. Ultrasound-guided oocyte retrieval was performed 36 h after hCG administration. The luteal phase was supported by progesterone (Progestan; Organon) 200 mg three times daily intravaginally, starting at the day of oocyte retrieval and continued for 2 weeks. In case of pregnancy, luteal support was continued for another 3 weeks.
The day before oocyte retrieval, dishes containing droplets of culture medium were prepared. In case of insemination, oocytes were cultured in either 50 ml droplets of IVF-50 TM (Vitrolife group) or K-SIFM (Cook group) medium and inseminated with approximately 50 000 progressively motile spermatozoa. After checking for the presence of pronuclei at 18 -20 h after insemination, zygotes were subsequently transferred to either G1 TM Version 3 (Vitrolife group) or K-SICM (Cook group) medium and cultured individually in 5 ml droplets. In case of ICSI, oocytes were individually cultured in either G1 TM Version 3 (Vitrolife group) or K-SICM (Cook group) medium immediately after injection. All media from both suppliers were ready to use and included 5 mg/ml pharmaceutical grade human serum albumin. Culture droplets for both groups were covered by mineral oil (Irvine Scientific, Orange Medical, Tilburg, The Netherlands). Culture was performed in a 5% O 2 , 6% CO 2 and 89% N 2 environment. Embryonic development was recorded daily, and embryos were given a morphological grade (1-4, with grade 4 being the best grade: regular, even sized blastomeres with ,20% fragmentation and absence of multinucleated blastomeres). Embryo transfer was performed on Day 2 after oocyte retrieval, or, in a minority of cases, for reasons of convenience, on Day 3. Our standard transfer policy consisted of the transfer of a single embryo when female age was ,38 years and at least one good quality embryo was available. In all other cases, two embryos were transferred. Embryos that had reached the 4-cell stage on Day 2, or the 8-cell stage on Day 3, in combination with having the best morphological grade, were classified as good quality embryos.
Data collection and statistical analysis
Pregnancy was determined by a urine hCG test (detection limit 50 IU/l) performed 14-16 days after embryo transfer. Clinical pregnancy was defined as the presence of a gestational sac and fetal heart beat on ultrasound performed 5-6 weeks after embryo transfer. Implantation rate was defined as the percentage of gestational sacs (with or without heart beat) per number of transferred embryos. When the pregnancy test was positive but no gestational sac was observed on ultrasound, a singleton implantation was considered to have occurred. In case of pregnancy, patients were asked to report the outcome and their obstetricians or midwives were contacted to obtain information about complications during pregnancy (such as gestational diabetes, hypertension and pre-eclampsia) and perinatal outcome. Only singleton live births after 20 completed weeks of gestation resulting from transfer of fresh embryos were included in the data analysis. Gestational duration was determined by subtraction of the oocyte retrieval date from the date of birth and the addition of 14 days. To compare singleton children born at different gestational ages and from different gender, a z-score (weight of individual child 2 median weight of a reference population of children born at the same gestational age and of the same gender divided by SD) was assigned to each child (Oken et al., 2003; Land, 2006) . Smoking habits, parental weight and height were documented at the start of the IVF treatment cycle.
To compare differences, Student's t-test was used for continuous variables and the x 2 -test was used for binary variables. When appropriate, Yates' correction was applied. Two-sided P-values of 0.05 or less were considered to indicate statistical significance. Besides adjustments for gestational age and gender by using a z-score in evaluating differences in birthweight in the two study groups, the type of culture medium together with several other variables that could possibly affect birthweight were entered into a multiple linear regression analysis model as covariates in order to assess their relative contribution to outcome.
Results
A total of 826 oocyte retrievals representing the first IVF treatment cycle of 826 consecutive patients who fullfilled our data inclusion criteria were performed during the study period. For 414 patients, culture media from Vitrolife were used, while for 412 patients, culture media from Cook were used. Patient and cycle characteristics were comparable in the two study groups when all 826 cycles were analyzed, except that signifcantly more cycles in the Cook group involved ICSI (Table I ). In the 188 cycles that resulted in a singleton live birth, maternal height and weight, as well as paternal weight, were slightly but significantly higher in the Vitrolife group (Table I) . Characteristics of transferred embryos were found to differ slightly between the two groups. Embryos in the Vitrolife group had a significantly higher mean number of cells, whereas embryos in the Cook group had a significantly higher morphological grade (Table II) . Single embryo transfer was performed in a significantly higher proportion of the cycles in the Cook group. Pregnancy rate and clinical pregnancy rate were significantly higher in the Vitrolife group, as was the implantation rate (Table III) . Of the pregnancies resulting in a singleton live birth, no significant differences were found with respect to the occurence of complications during pregnancy such as gestational diabetes, hypertension and pre-eclampsia (9 ¼ 8.2% in the Vitrolife group and 4 ¼ 5.1% in the Cook group). Mean birthweight as well as mean birthweight adjusted for gestational age and gender (z-score) of all live born singletons was significantly lower in the Cook group (Table IV) . This was also illustrated by the birthweight distribution curves (Fig. 1) in which the percentage of children in each birthweight category (e.g. children weighing 1500 and ,1750 g, etcetera) of the total number of children is shown. When several possible confounding factors [parity, characteristics of both parents (age, height, weight, BMI, smoking habits), duration of subfertility, type of IVF treatment (insemination or ICSI), time of embryo transfer (Day 2 or 3), number of transferred embryos (1 or 2) and complications during pregnancy] were entered into a multiple linear regression analysis model together with gestational age, gender of the infant and type of culture medium, only gestational age (P , 0.0001), parity (P ¼ 0.005), gender (P ¼ 0.03), age of the mother (P ¼ 0.03) and type of culture medium (P ¼ 0.01) were significantly associated with birthweight (multiple correlation coefficient R ¼ 0.697). To further evaluate the effect of several confounding factors, we analyzed a subgroup of children that were born from term pregnancies (37 weeks), and in which no medical complications were recorded. Furthermore, to exclude pregnancies where other (unknown) circumstances caused grossly abnormal birthweight, we included only cases with both normal birthweight (.2500 and ,4500 g) as well as normal birthweight for gestational age (.10th percentile and ,90th percentile) in this supplementary analysis. Also in this selected group, mean birthweight (P ¼ 0.016) as well as z-score (P ¼ 0.013) were significantly higher in the Vitrolife group mother (age, height and weight), gestational age, parity, gender and number of transferred embryos (1 or 2). When height and weight of parents in the Vitrolife group were compared with the parents in the Cook group, the height of the mothers + SEM (169.9 + 0.6 versus 168.9 + 1.0 cm, P ¼ 0.38), weight of the mothers + SEM (69.4 + 1.1 versus 67.3 + 1.3 kg, P ¼ 0.23), height of the fathers + SEM (182.3 + 0.9 versus 181.7 + 0.9 cm, P ¼ 0.63) and weight of the fathers + SEM (85.4 + 1.4 versus 82.2 + 1.6 kg, P ¼ 0.14) did not differ significantly in this selected group.
Discussion
Our study shows that the culture medium used for IVF treatment has a significant effect not only on early embryonic development, but also on subsequent fetal development and the newborn child. Pregnancy rate, and clinical pregnancy rate were significantly higher in the Vitrolife group. This finding is in agreement with an earlier study showing that, in a subset of patients with at least five embryos put into culture, the use of the previous version of the Vitrolife sequential media (G1.2/G2.2) resulted in a significant higher pregnancy rate as compared with the use of Cook media (Van Langendonckt et al., 2001) . To the best of our knowledge, our study is the first to show that culture conditions can affect birthweight of newborns. Many factors affect birthweight, of which gestational age at delivery, fetal gender and whether the child is a singleton or part of a multiple are the most important (Cogswell and Yip, 1995; Oken et al., 2003) . Other factors include maternal factors such as parity (Zhang and Bowes, 1995) , maternal height, weight and BMI (Cogswell and Yip, 1995; Rosenberg et al., 2005) , race (Zhang and Bowes, 1995) , pregnancy related factors such as gestational diabetes, hypertension and preeclampsia (Rosenberg et al., 2005) and lifestyle factors such as smoking (Cogswell and Yip, 1995) . Furthermore, a history of subfertility is associated with an increased incidence of obstetric and perinatal complications, as well as with a decreased average birthweight in singleton pregnancies conceived either spontaneously (Thomson et al., 2005; De Geyter et al., 2006) or after controlled ovarian stimulation (Ombelet et al., 2006) . Recently, it has been shown that the number of transferred embryos is an IVF treatment-related factor significantly affecting perinatal outcome as average birthweight is lower, and preterm birth and low birthweight are significantly more common in singletons resulting from the transfer of two embryos as compared with singletons born after single embryo transfer . This finding is probably related to the relatively high frequency of vanishing twins after the transfer of two embryos . Duration of subfertility and parameters of ovarian stimulation such as dosage of gonadotrophins and number of oocytes retrieved have been shown to have no quantitative association with birthweight (Griesinger et al., 2008) . In our study, several of the above mentioned possible confounding factors were found to differ between the study groups. First, in the cycles that resulted in a singleton live birth, maternal height and weight, as well as paternal weight, were slightly but significantly higher in the Vitrolife group (Table I) , although this was not the case in the total group of cycles. At present, we do not have an explanation for this finding. It is important to note that in our clinic we admit obese female patients (BMI . 30 kg/m 2 ) only in exceptional cases to our IVF program. Obese patients are especially at risk for pregnancy complications, adverse pregnancy outcomes and increased birthweight (Schrauwers and Dekker, 2009 ). In our study, only nine of the total number of 188 mothers of singletons had a BMI of . 30 kg/m 2 with the highest BMI being 33.3 kg/m 2 .
Second, the proportion of cycles in which two embryos were transferred differed between the two study groups. This difference is related to the different embryo characteristics (Table II) in both media study groups in combination with our transfer policy, and not to differences in patient or cycle characteristics (data not shown). The fact that more often double embro transfer was performed in the Vitrolife group explains, at least partly, the higher pregnancy rate observed in this group. It could also theoretically lead to a lower mean birthweight of singletons in the Vitrolife group due to vanishing twins . In our series, however, only in three pregnancies (two in the Vitrolife group and one in the Cook group) that resulted in a singleton birth, more than one gestational sac was observed by ultrasound performed 5-6 weeks after embryo transfer. From the multiple linear regression analysis, it is however clear that the type of culture medium is significantly associated with birthweight regardless of the above mentioned possible confounders, both when the total group of live born singletons was analyzed as well as when a subgroup was analyzed in which children were excluded if they were born either from preterm pregnancies, or from pregnancies that had medical complications, or were of abnormal birthweight; in these children risk factors other than the in vitro culture conditions are more likely to play an important part (Mongelli and Gardosi, 2000; Das et al., 2004) .
In the present study, we used an alternate case, quasi-random method of patient allocation, which is not the optimal study design. However, the fact that the order of treatments on a given day, which directly determined the allocation to a study group, was planned by clinical personnel who were unaware of the allocation procedure in the laboratory makes the assignment of allocation procedure in fact random.
Whether our findings are in any way related to the observed effects of certain in vitro culture conditions in animal species is speculative. The effects demonstrated in the present study are certainly less severe. In sheep and cattle, increases of 20230% in mean birthweight relative to offspring conceived naturally are reported and even increases of twice the normal birthweight are not uncommon (see reviews Young et al., 1998; Sinclair et al., 2006) . In contrast, in the mouse, in vitro culture in suboptimal media gives rise to offspring that have a 20% decrease in birthweight (Khosla et al., 2001) . Several studies have identified the supplementation of media with serum (from any source) as at least one of the factors known to cause the so-called large offspring syndrome in cattle and sheep (Young et al., 1998; Sinclair et al., 2006; Rooke et al., 2007) and the increased incidence of smaller fetuses in mice (Khosla et al., 2001) . Both types of media used in our present study did contain human serum albumin as a protein source instead of serum.
It has been shown in animal studies that certain in vitro culture conditions can lead to alterations in mRNA expression patterns in preimplantation embryos that may persist throughout fetal development until birth and it is hypothesized that abnormal gene expression of certain developmentally important genes are responsible for the observed abnormalities in the resulting offspring (Wrenzycki et al., 2005; Rivera et al., 2008) . Examples of such culture conditions that have been shown to affect gene expression as well as fetal development are the addition of serum (Rooke et al., 2007) , or ammonium (Lane and Gardner, 2003) to the medium, and a high oxygen concentration above the medium (Kind et al., 2004) . In mice it has been demonstrated that in vitro culture has long-term effects on mRNA expression of imprinted genes (Rivera et al., 2008) , not only affecting fetal development but even behavior of the resulting offspring (Fernández-Gonzalez et al., 2004) . Besides in vitro culture, also conditions that are known to alter the in vivo environment of preimplantation embryos such as a high protein diet during the peri-conceptional period can lead to aberrant gene expression and subsequent abnormal fetal development (Powell et al., 2006) . Epigenetic modifications are thought to be responsible for the altered gene expression, and imprinted genes such as IGF2R in sheep (Young et al., 2001) and H19 in mice (Lane and Gardner, 2003; Fauque et al., 2007) seem to be especially sensitive to suboptimal culture conditions.
It has also been speculated that in vitro culture of human embryos may lead to epigenetic perturbations in a similar way as in animal species. There are indications that the incidence of rare imprinting disorders such as Beckwith -Wiedemann syndrome is increased in children resulting from IVF (Lim et al., 2009; Manipalviratn et al., 2009) , although it has been suggested that the subfertility status of the parents and/or the hormonal stimulation were causal factors rather than the in vitro culture per se (Chang et al., 2005; Doornbos et al., 2007) . Furthermore, a recent study found evidence that prepubertal IVF children born at term after singleton pregnancies are taller and have higher levels of serum IGF-II and a different lipid profile compared with their non-IVF matched controls; this finding that was speculated to originate from epigenetic changes through altered methylation of genes involved in growth and metabolism (Miles et al., 2007) .
To conclude, our results indicate that a period as short as 2-3 days of in vitro culture of human embryos can have a significant effect on birthweight of the resulting children. This could explain, at least in part, the significantly higher risk for low birthweight in IVF singletons compared with the general population, as has been described in several studies (Helmerhorst et al., 2004; Jackson et al., 2004; Sutcliffe and Ludwig, 2007; Ceelen et al., 2008) . The use of optimal culture media during IVF treatment may help to avoid low birthweight. The facts that pregnancies resulting from IVF represent 2% of all births in Western countries (Sutcliffe and Ludwig, 2007) , and that low birthweight children (and in particular, low birthweight at term) are at elevated risk of perinatal complications (McIntire et al., 1999) and illnesses later in life (Barker, 2004) , place a huge responsibility on the shoulders of manufacturers of culture media for human IVF and on those of the IVF practitioners that use them. More research has to be performed to unravel the impact of in vitro culture of gametes and embryos on the health of future children.
